ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients New analysis from the IMROZ phase 3 study of Sarclisa-VRd demonstrated higher and ...

Paris, France – December 6, 2024. Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella (consumer healthcare) to CD&R, the financial information ...

Autoimmune type 1 diabetes (T1D) is an autoimmune progressive and lifelong condition that can develop regardless of age, lifestyle or family history. Individuals with autoimmune T1D are typically ...

Recommendation based on IMROZ phase 3 study demonstrating Sarclisa in combination with VRd significantly improved progression-free survival, compared to standard-of-care VRd alone If approved, ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the US suffer from chronic spontaneous urticaria (CSU) that is ...

Although presymptomatic T1D (Stages 1 and 2) can be detected months or years before symptoms appear, most people are not diagnosed until they feel unwel. 10 11 Over the past 50 years, scientists ...

Ce communiqué contient des déclarations prospectives. Ces déclarations ne constituent pas des faits historiques. Ces déclarations comprennent des projections et des estimations ainsi que les ...

In the annual diversity, equity and inclusion (DE&I) Report, Sanofi takes stock of progress on the three pillars of the DE&I strategy. On the ‘building representative leadership’ pillar: 45%1 of ...

In many countries, minimum wages are insufficient to guarantee that workers and their families can meet basic needs. Sanofi is proud to go beyond the minimum by committing to a living wage for all ...

Since January 1, 2024, the program's flagship measure - 12 months' salary, social protection and employment guarantee - has been in place for all employees affected by cancer, regardless of their ...

Alizée: Lors de mon bilan de santé annuel, mon médecin a remarqué que mon taux de glycémie était légèrement plus élevé qu'il ne devrait l'être. Heureusement, il n'y avait pas de raison immédiate de ...

Janvier 2022 a marqué un tournant dans la prise en charge du diabète de Type 1. Après plus d’un siècle de traitements à base d’insuline, patients et médecins ont désormais une nouvelle option : la ...